The slip
PARKINSON RECEIPTno. 7197
23 Oct 2026, 04:56 UTCdopamine neurons, braak
predictionLRPPRC in dopamine neurons tracks Braak Lewy-body stage
registeredaa5cba3a6c143496
discovery+0.41 p=0.277 n=9
replication+0.30 p=0.441 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.41, p 0.277)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT621bcf8df72e3f5730242d7a…
follows c419be9d9e5b…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7197: LRPPRC in dopamine neurons, braak
- power
- full sample +0.37 (p 0.130, n 18), 95% CI -0.12 to +0.71. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.36 (p 0.145, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.38 (p 0.116, n 18). could be the mix.
- skeptic
- leave-one-out range +0.28 to +0.54, sign flips 0; without severely affected donors +0.37 (p 0.130, n 18). fragile.
- cell type
- strongest in OPCs: +0.70 (p 0.0011, n 18) vs +0.37 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRPPRC in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up LRPPRC · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.52 p 0.062 (needs p < 2.9e-4)